LGND

Ligand Pharmaceuticals Incorporated News Headlines

$54.7
*  
1
1.86%
Get LGND Alerts
*Delayed - data as of Nov. 28, 2014 10:37 ET  -  Find a broker to begin trading LGND now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    LGND Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Ligand Pharmaceuticals: Investor Day Highlights The Big 6, All Undervalued Catalysts
11/24/2014 9:04:00 AM - Seeking Alpha


GSK Reports EU Submission For Severe Aplastic Anemia Indication For Revolade
11/12/2014 9:24:00 AM - RTT News


Gilead presents data from three HCV drug combo studies
11/11/2014 9:05:00 AM - Seeking Alpha


Ligand Pharmaceuticals' Shares Fall on Q3 Earnings Miss - Analyst Blog
10/29/2014 1:00:00 PM - Zacks.com


Ligand Pharmaceuticals Has Rich A Valuation Now But Is Undervalued For Long Term Success
10/29/2014 11:34:00 AM - Seeking Alpha


Update: Ligand Posts Consecutive Earnings Beat
10/28/2014 4:21:00 PM - Seeking Alpha


Ligand Pharma Q3 Profit Down; Reiterates Annual Guidance
10/27/2014 8:42:00 AM - RTT News


Sector Update: Health-Care Shares Flat Before Opening Bell
10/27/2014 7:49:25 AM - MT Newswires


Sector Update: Health Care
10/27/2014 7:45:32 AM - MT Newswires


Will Pfizer (PFE) Disappoint This Earnings Season? - Analyst Blog
10/24/2014 4:20:00 PM - Zacks.com


Will Merck (MRK) Pull a Surprise this Earnings Season? - Analyst Blog
10/24/2014 4:10:00 PM - Zacks.com


Will Ligand Pharmaceuticals Beat Q3 Earnings Estimates? - Analyst Blog
10/24/2014 4:00:00 PM - Zacks.com


Will Amgen (AMGN) Disappoint in the Q3 Earnings Season? - Analyst Blog
10/24/2014 3:45:00 PM - Zacks.com


Will Vertex Pharmaceuticals (VRTX) Post a Lower Q3 Loss? - Analyst Blog
10/24/2014 3:11:00 PM - Zacks.com


Can Epizyme (EPZM) Surprise This Earnings Season? - Analyst Blog
10/24/2014 2:48:00 PM - Zacks.com


Ligand (LGND) Shares March Higher, Can It Continue? - Tale of the Tape
10/24/2014 8:27:05 AM - Zacks.com


Why Earnings Season Could Be Great for Ligand (LGND) - Tale of the Tape
10/24/2014 7:36:00 AM - Zacks.com


Omeros Falls as Enrollment for OMS824 Study is Suspended - Analyst Blog
10/23/2014 3:10:00 PM - Zacks.com


Vertex Pharmaceuticals' Kalydeco Wins FDA Panel Backing - Analyst Blog
10/22/2014 4:54:00 PM - Zacks.com


Will Bristol-Myers (BMY) Disappoint This Earnings Season? - Analyst Blog
10/22/2014 4:00:00 PM - Zacks.com


Will Agenus (AGEN) Incur Wider-than-Expected Q3 Loss? - Analyst Blog
10/22/2014 3:30:00 PM - Zacks.com


Amgen Gains as Third Point Suggests Split - Analyst Blog
10/22/2014 12:50:00 PM - Zacks.com


Biogen's Q3 Earnings Top Estimates, View Raised Again - Analyst Blog
10/22/2014 12:10:00 PM - Zacks.com


Actelion Misses Q3 Earnings Expectation, Ups 2014 Guidance - Analyst Blog
10/22/2014 10:40:00 AM - Zacks.com


Pacific Biosciences to Incur Narrower-than-Expected Q3 Loss - Analyst Blog
10/21/2014 4:50:00 PM - Zacks.com